Pure RBC aplasia and myasthenia gravis. Coexistence of two diseases associated with thymoma.
Socinski. M A MA; Ershler. W B WB; Frankel. J P JP; Albertini. R J RJ; Ciongoli. A K AK; Krawitt. E L EL; Burns. S L SL; Mangan. K F KF
Key Findings
- PRCA and MG occurred together in a patient with a thymoma
- Serum autoantibodies and an inhibitor of red‑cell production were detected
- Circulating thymosin‑alpha‑1 was elevated, but the thymoma was only found after death
Practical Outcomes
- The findings suggest thymosin‑alpha‑1 may rise in certain autoimmune diseases, but they don’t provide a protocol or dosage for using the peptide to boost longevity or performance. Biohackers should view this as a disease‑marker observation rather than a therapeutic guide.
Summary
A rare case showed a patient with both red‑blood‑cell failure and muscle weakness linked to a thymus tumor, and this patient also had higher levels of thymosin‑alpha‑1 in the blood. The study is just a single report and doesn’t give any new ways to use the peptide for health improvement.
Abstract
Pure RBC aplasia (PRCA) and myasthenia gravis (MG) are occasionally associated with thymoma, although the occurrence of all three in a single patient is rare. We describe a patient in whom PRCA and MG occurred in conjunction with the presence of serum autoantibodies, evidence for a serum inhibitor of erythropoiesis, and elevation of circulating thymosin alpha 1. Although a thymoma could not be detected before death, postmortem examination of the mediastinum found scattered cells within a nodule, suggestive of a lymphoepithelial thymic neoplasm.
Study Information
pubmed
1983